Cowen and Company’s SkinHealth Systems SKIN Stock Holding History

Cowen and Company’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$14K	–	724
2022 Q3	$14K	Buy	+20,000	New	+$253K	﹤0.01%	385

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen and Company's SKIN Position: Q4 2022 in Review

Cowen and Company sold out of SkinHealth Systems (SKIN) in Q4 2022, closing a stake of 20,000 shares — an estimated $14K sold.

Cowen and Company first reported a position in SKIN in Q3 2022 and held it in 1 quarter. The position peaked at $14K in Q3 2022. 158 funds tracked by Wall St. Rank hold SKIN as of Q4 2022.

Cowen and Company reported no remaining SkinHealth Systems position as of Q4 2022 after selling out during the quarter.
Cowen and Company sold 20,000 SkinHealth Systems shares in Q4 2022, an estimated $14K.
Cowen and Company first reported a position in SkinHealth Systems in Q3 2022 and held it in 1 quarter.
Cowen and Company's SkinHealth Systems position peaked at $14K in Q3 2022.
158 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.